🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Predicting Language Recovery in Acute Stroke Patients in the Neurovascular Intensive Care Unit: An Exploratory Study With the Core Assessment of Language Processing.

Recruitingn/aAges 18 Years - 85 YearsAllAssistance Publique - Hôpitaux de Paris
NCT06817642 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Introduction: Stroke affects one person every 4 minutes in France (i.e. more than 140,000 new cases per year) resulting in cognitive and motor disorders. Aphasia is one of the most devastating cognitive disorders that persist in the late phase. However, early treatment of aphasia can improve the effects of rehabilitation. Identifying, as early as possible, the patients most at risk of presenting persistent language disorders in the late phase would make it possible to improve their management and increase the effects of cognitive rehabilitation on their language abilities. The aim of this project is to evaluate whether the Core Assessment of Language Processing (CALAP) assessed in the acute phase of stroke can predict language abilities in the late phase. Hypothesis/Objective: The primary objective is to determine whether the language abilities of patients in the acute phase of stro

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age: between 18 and 85 years old * Inpatient in the initial phase of stroke (between 0 and 21 days after stroke) * Hemispheric stroke, ischemic or haemorrhagic * Ability to participate in tests * Francophone * 4≤ NIHSS score ≤21 or if NIHSS score \< 4, LAST score \[0-13\] * Non-opposition to participation in tests Exclusion Criteria: * Severe alertness impairment incompatible with test participation, NIHSS score 1a. different from 0 * Severe overall intellectual deterioration incompatible with test participation * Patients who may have a visual or hearing impairment incompatible with participation in CALAP * History of stroke * Posterior fossa stroke
💊

What it tests

  • Data recovery from language and cognitive assessment
📍

Where

1 site
Assistance Publique Hôpitaux de Paris - Hôpital Henri Mondor
Créteil, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy